Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02075502 · ClinicalTrials.gov registry record · NA

Community Walking Exercise for Patients With Peripheral Artery Disease

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
70
Enrollment target

NCT02075502: Completed NA study, sponsored by University of Minnesota.

NCT02075502 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02075502, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

The primary aim of the study is to determine the effect of a community-based walking exercise program with detailed training, monitoring, and coaching (TMC) exercise components enhanced by community-based participatory research (CBPR) practices (TMC+) on the primary outcome of peak walking time (PWT) in patients with peripheral artery disease (PAD).

Interventions

  • BEHAVIORAL Exercise therapy
  • PROCEDURE lower extremity ET
  • PROCEDURE peripheral open intervention

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2014-02-01
Est. Completion 2020-02-12
Phase NA
University of Minnesota

966 total trials

What the finished NCT02075502 record still lists

NCT02075502 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 3 interventions - of which Exercise therapy is the first listed.

NCT02075502 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02075502 about?

NCT02075502 is a clinical study titled "Community Walking Exercise for Patients With Peripheral Artery Disease". The primary aim of the study is to determine the effect of a community-based walking exercise program with detailed training, monitoring, and coaching (TMC) exercise components enhanced by community-based participatory research (CBPR) practices (TMC+) on the primary outcome of peak walking time (PWT...

What is the current status of trial NCT02075502?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2014-02-01. Estimated completion is 2020-02-12.

What interventions are being tested in trial NCT02075502?

The interventions under investigation include: Exercise therapy (BEHAVIORAL), lower extremity ET (PROCEDURE), peripheral open intervention (PROCEDURE).

Who is sponsoring clinical trial NCT02075502?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02075502's enrollment target sits among peer trials

70 1103rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02075502, the US trial registry maintained by the National Library of Medicine. NCT02075502 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.